Coronary artery spatial distribution of acute myocardial infarction occlusions

Circulation

Volumn 110, Issue 3, 2004, Pages 278-284

  Wang, John C ^a   Normand, Sharon Lise T ^b   Mauri, Laura ^a   Kuntz, Richard E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Coronary disease; Myocardial infarction; Plaque

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPATIAL MAPPING; EPICARDIUM MAPPING; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY CIRCUMFLEX BRANCH; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RIGHT CORONARY ARTERY; RISK; RUPTURE; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION HEART INFARCTION; TISSUE DISTRIBUTION; VULNERABLE ATHEROSCLEROTIC PLAQUE;

CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 3242714289     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000135468.67850.F4     Document Type: Article

References (47)

1. Fuster V, Lewis A. Conner Memorial Lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
2. Corti R, Farkouh ME, Badimon JJ. The vulnerable plaque and acute coronary syndromes. Am J Med. 2002;113:668-680.
3. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol. 2001;37:1284-1288.
4. Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process, Circulation. 2002;106:760-762.
5. Naghavi M, Libby P, Falk E, et al, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108:1772-1778.
6. Schwartz RS, Bayes-Genis A, Lesser JR, et al. Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers. J Interv Cardiol. 2003;16:231-242.
7. Kullo IJ, Edwards WD, Schwartz RS. Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med. 1998;129:1050-1060.
8. Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation. 1999;99: 847-851.
9. Cespedes EI, de Korte CL, van der Steen AF, et al. Intravascular elastography: principles and potentials. Semin Interv Cardiol. 1997;2:55-62.
10. de Korte CL, Pasterkamp G, van der Steen AF, et al. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation. 2000;102:617-623.
11. Takano M, Mizuno K, Okamatsu K, et al. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol. 2001;38:99-104.
12. Brezinski ME, Tearney GJ, Bouma BE, et al. Optical coherence tomography for optical biopsy: properties and demonstration of vascular pathology. Circulation. 1996;93:1206-1213.
13. Romer TJ, Brennan JF 3rd, Fitzmaurice M, et al. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation. 1998;97:878-885.
14. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347:1447-1451.
15. Stefanadis C, Toutouzas K, Tsiamis E, et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol. 2001;37:1277-1283.
16. Fayad Z, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001;89:305-316.
17. Callister TQ, Raggi P, Cooil B, et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998;339:1972-1978.
18. Kopp A, Schroeder S, Baumbach A, et al. Non-invasive characterisation of coronary lesion morphology and composition by multislice CT: first results in comparison with intracoronary ultrasound. Eur Radiol. 2001; 11:1607-1611.
19. Worthley SG, Helft G, Fuster V, et al. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model, Atherosclerosis. 2000;150:321-329.
20. Worthley SG, Helft G, Fuster V, et al. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation. 2000;101:2956-2961.
21. Meier B, Ramamurthy S. Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn. 1995;36:295-297.
22. Stefanadis C, Vavuranakis M, Toutouzas P. Vulnerable plaque: the challenge to identify and treat it. J Interv Cardiol. 2003;16:273-280.
23. Kolodgie FD, Burke AP, Farb A, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001;16:285-292.
24. Loree HM, Kamm RD, Stringfellow RG, et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 1992;71:850-858.
25. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
26. Gertz SD, Roberts WC. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol. 1990;66:1368-1372.
27. Davies MJ. Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur Heart J. 1995;16(suppl L):3-7.
28. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life, Eur Heart J. 1990;11 (suppl E):3-19.
29. Pasterkamp G, Schoneveld AH, van der Wal AC, et al. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol. 1999;19:54-58.
30. Reiber JH, Jukema W, van Boven A, et al. Catheter sizes for quantitative coronary arteriography. Cathet Cardiovasc Diagn. 1994;33:153-155; discussion 156.
31. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography): developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33:1756-1824.
32. Alderman E, Stadius M. The angiographic definitions of the Bypass Angioplasty Revascularization Investigation. Coron Artery Dis. 1992;3: 1189-1207.
33. Killip T, Fisher L, Mock M, for the CASS Investigators. National Heart, Lung, and Blood Institute Coronary Artery Surgery Study (CASS): a multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation. 1981;63(suppl I, pt II):I-1-I-81.
34. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999;82:269-272.
35. Fujii K, Kobayashi Y, Mintz GS, et al. Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation. 2003;108: 2473-2478.
36. Willerson JT, Kereiakes DJ. Endothelial dysfunction. Circulation. 2003; 108:2060-2061.
37. el Fawal MA, Berg GA, Wheatley DJ, et al. Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. Br Heart J. 1987;57:329-335.
38. MacIsaac AI, Thomas JD, Topol EJ. Toward the quiescent coronary plaque. J Am Coll Cardiol. 1993;22:1228-1241.
39. Shah P. Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin. 1996;14:17-29.
40. Feldman C, Stone P. Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Curr Opin Cardiol. 2000;15:430-440.
41. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001;103:1967-1971.
42. Shah PB, Cutlip DE, Popma JJ, et al. Incidence and predictors of late total occlusion following coronary stenting. Cathet Cardiovasc Interv. 2003; 60:344-351.
43. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217-225.
44. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339: 1665-1671.
45. Baim DS, Cutlip DE, Midei M, et al. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001;87:157-162.
46. Baim DS, Cutlip DE, O'Shaughnessy CD, et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001;87:152-156.
47. Strong JP, Eggen DA, Oalmann MC. The natural history, geographic pathology, and epidemiology of atherosclerosis. In: Wissler RW, Geer JC, eds. The Pathogenesis of Atherosclerosis. Baltimore, Md: Williams & Wilkins; 1972.